← Back to Search

Continuous Glucose Monitoring

Real-time glucose sensor for Diabetes (Gerber RTSA Trial)

Phase 3
Waitlist Available
Led By Patricia Fechner, MD
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children less than 4 years of age with Type I diabetes for at least 3 months
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Gerber RTSA Trial Summary

The purpose of this study is to see if the use of a real-time glucose sensor improves diabetes control in young children (less than 4 years old) with Type I diabetes when they are initiated on insulin pump therapy.

Eligible Conditions
  • Diabetes

Gerber RTSA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Gerber RTSA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduce blood glucose variability among 0-3 year old children with type I diabetes.
Secondary outcome measures
Number of adverse events

Gerber RTSA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Real-time glucose sensorExperimental Treatment1 Intervention
Subjects wear real-time glucose sensor
Group II: ControlActive Control1 Intervention
Observational arm

Find a Location

Who is running the clinical trial?

Seattle Children's HospitalLead Sponsor
302 Previous Clinical Trials
5,216,967 Total Patients Enrolled
MedtronicIndustry Sponsor
606 Previous Clinical Trials
828,625 Total Patients Enrolled
4 Trials studying Diabetes
164 Patients Enrolled for Diabetes
The Gerber FoundationOTHER
41 Previous Clinical Trials
5,956 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
2008. "The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00875290.
All > Gestational Diabetes > Diabetes
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top